Wednesday, November 17, 2021
Print Current Day:
|
|
SESSION 23 SCHEDULE | |
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
|
|
x | |
6:40 AM - 6:45 AM | Do Diabetic Patients With CLTI And Substantial Foot Necrosis Have Time For An Endovascular First Strategy: Why Primary Open Bypass Treatment Is Better |
Presenter(s):Katariina M. Noronen, MD, PhD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
6:46 AM - 6:51 AM | Key New Developments In Endovascular Treatments For CLTI |
Presenter(s):Sahil A. Parikh, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS | |
6:52 AM - 6:57 AM | Technical Tips For Vessel Prep Before DCBs And DESs: It Is Different And Not Simple |
Presenter(s):Erwin Blessing, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
6:58 AM - 7:03 AM | Thirteen Technical Tips For Safe Radial Access For Renal/Visceral And Lower Extremity Interventions: How Far Distally In The Leg Can Lesions Be Treated |
Presenter(s):Craig M. Walker, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
7:04 AM - 7:09 AM | What Are The Downsides To Trans-Radial Or Pedal Access |
Presenter(s):Gary M. Ansel, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE | |
7:10 AM - 7:15 AM | Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion And Getting A Resistant Balloon To Go Over The Wire |
Presenter(s):Marco G. Manzi, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
7:16 AM - 7:22 AM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Craig M. Walker, MD / James F. McKinsey, MD |
|
x | |
PROGRESS IN ATHERECTOMY | |
7:22 AM - 7:27 AM | New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty |
Presenter(s):George L. Adams, MD, FACS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
7:28 AM - 7:33 AM | Value Of Phoenix Atherectomy And Stellarex DCB For Infrapopliteal Lesions: Why IVUS Guidance Is Beneficial: 1-Year Results In CLTI Patients |
Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
7:34 AM - 7:39 AM | Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial |
Presenter(s):Todd R. Vogel, MD, MPH Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
7:40 AM - 7:45 AM | Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View |
Presenter(s):James F. McKinsey, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
UPDATE ON THE SUPERA STENT | |
7:46 AM - 7:51 AM Power Point Presentation with Synched Audio |
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
Presenter(s):Peter C.J. Goverde, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
7:52 AM - 7:57 AM | Value And Technical Tips To Make The Supera Stent Work In Curved And Angulated Non-SFA Lesion Locations |
Presenter(s):Rajiv Parakh, MBBS, MS, FRCS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
DRUG ELUTING STENTS FOR BTK LESIONS | |
7:58 AM - 8:03 AM | 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:04 AM - 8:09 AM | What Is The Future For Bioresorbable DESs To Treat BTK Lesions: Good Long-Term Results Including The DISAPPEAR Trial Justify A New Trial: The LIFE-BTK Trial With The Esprit Stent From Abbott |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD / Steven Kum, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:10 AM - 8:15 AM | A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND Trial |
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:16 AM - 8:22 AM | Panel Discussion |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Kenneth Ouriel, MD, MBA / Sahil A. Parikh, MD |
|
x | |
8:22 AM - 8:27 AM | Older And More Recent Meta-Analyses Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: A More Recent Study Reveals Increased Amputation Rates With Paclitaxel Coated Devices: What About Mortality |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:28 AM - 8:33 AM | Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices: Initial Thoughts About Katsanos’ Recent Amputation Data |
Presenter(s):Christian A. Behrendt, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:34 AM - 8:39 AM | Real World Big Data Patient-Level Evidence Confirms No Harm From Paclitaxel Coated Devices For Treating Fempop Disease: Update On Medicare Data From Over 150,000 Patients |
Presenter(s):Eric A. Secemsky, MD, MSc / Robert Yeh, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:40 AM - 8:45 AM | Mortality Rates After Paclitaxel Coated Device Use In Patients With Both Critical Limb Ischemia (CLI) And Claudication: Two Systematic Reviews And Meta-Analyses Of Randomized Controlled Trials Show NO Increased Mortality With Paclitaxel Coated Devices Up To 5 Years |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Andrew Holden, MBChB / Krystal Dinh, MD / Peter A. Schneider, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
RELEVANT COMMENTS AS SHORT SUMMARY [SS] TOPICS (4 ¾-MINUTE TALKS) | |
8:46 AM - 8:51 AM | [SS] The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data: Initial Thought About Katsanos’ Recent Meta-Analysis Showing Increased Amputation Rates With Paclitaxel Coated Devices |
Presenter(s):Peter A. Schneider, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:51 AM - 8:56 AM | [SS] New Data On The Paclitaxel Mortality Controversy: Should You Continue Using These Devices |
Presenter(s):Gary M. Ansel, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
8:56 AM - 9:01 AM | [SS] VQI Data Do Not Support The Paclitaxel Increased Mortality Signal |
Presenter(s):Daniel J. Bertges, MD / Jack L. Cronenwett, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
9:01 AM - 9:08 AM | Panel Discussion |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS)
|
|
x | |
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
9:08 AM - 9:13 AM Power Point Presentation with Synched Audio |
Cost Effectiveness Of Drug Eluting Technologies For Femoropopliteal Lesions: They Are Worth The Increased Device Costs |
Presenter(s):Stefan Mueller-Huelsbeck, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
9:14 AM - 9:19 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Effective In Fempop Lesions: Final 5-Year Data From The ILLUMENATE RCTs |
Presenter(s):Sean P. Lyden, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
9:20 AM - 9:25 AM | Pooled Data From The In.Pact RCT DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Continued Use Is Justified |
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
9:26 AM - 9:31 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 4-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
Presenter(s):Francesco Liistro, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
9:32 AM - 9:37 AM Power Point Presentation with Synched Audio |
Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
9:38 AM - 9:43 AM | Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA |
Presenter(s):Marianne Brodmann, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
9:44 AM - 9:49 AM | Panel Discussion |
9:49 AM - 10:02 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) Session 26 will continue after the Break. |
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS) | |
Moderator(s): Joseph L. Mills, MD / John R. Laird, MD | |
10:02 AM - 10:07 AM Power Point Presentation with Synched Audio |
New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment |
Presenter(s):Michael D. Dake, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
10:08 AM - 10:13 AM | Update On Clinical Trials Of The Boston Scientific Eluvia DES |
Presenter(s):William A. Gray, MD / Stefan Mueller-Huelsbeck, MD / Thomas Zeller, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
NEW INFORMATION ON BTK DCBs AND DESs | |
10:14 AM - 10:19 AM | The Sirolimus DCB BTK Era Begins – Current Experience With The Selution DCB And Design Of The SELUTION SLR .014 BTK IDE Trial: Early Results From Singapore And Europe |
Presenter(s):Patrick J. Geraghty, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
10:20 AM - 10:25 AM | 1-Year Results From The AcoArt II BTK DCB RCT Show Safety (No Increased Mortality) And Improved Patency Versus POBA |
Presenter(s):Francesco Liistro, MD / Wei Guo, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
10:26 AM - 10:31 AM | Why BTK DCB Trials Do Not Show Uniformly Better Results: Technical Factors Matter |
Presenter(s):Francesco Liistro, MD / Wei Guo, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
10:32 AM - 10:37 AM | Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions |
Presenter(s):Jihad A. Mustapha, MD / Miguel F. Montero-Baker , MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
10:38 AM - 10:43 AM | Panel Discussion |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Daniel G. Clair, MD / Marco G. Manzi, MD |
|
x | |
10:43 AM - 10:48 AM | Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Worthwhile Saving Limbs Especially In Vascular Patients |
Presenter(s):Philip P. Goodney, MD, MS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES | |
10:49 AM - 10:54 AM | Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses: When A Single Autologous Vein Is Inadequate |
Presenter(s):Joseph L. Mills, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
10:55 AM - 11:00 AM | PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Can Have Long-Term Patency And Limb Salvage And Are Worthwhile |
Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Hasan H. Dosluoglu, MD / Neal S. Cayne, MD / Mark A. Adelman, MD / Frank J. Veith, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:01 AM - 11:06 AM | For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option |
Presenter(s):R. Clement Darling III, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:07 AM - 11:12 AM | Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions |
Presenter(s):Matthew T. Menard, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:13 AM - 11:18 AM | Panel Discussion |
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI | |
11:18 AM - 11:23 AM | What Is The Real Prevalence Of No Option Anatomy Among The CLTI Population: What Is The Role For Foot Vein Arterialization: Impact Of The PROMISE I Trial With The LimFlow System |
Presenter(s):Peter A. Schneider, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:24 AM - 11:29 AM Power Point Presentation with Synched Audio |
Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:30 AM - 11:35 AM Power Point Presentation with Synched Audio |
Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t |
Presenter(s):Roberto Ferraresi, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:36 AM - 11:41 AM | 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing |
Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:42 AM - 11:47 AM | How To Perform The LimFlow Procedure: Equipment Required And Technical Tips |
Presenter(s):Miguel F. Montero-Baker , MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:48 AM - 11:53 AM | Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results |
Presenter(s):Richard F. Neville, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Mark A. Adelman, MD / Anahita Dua, MD, MS, MBA |
|
x | |
1:00 PM - 1:04 PM | 3-Year Results From The BioMimics 3D Swirling Flow Stent In The MIMICS-2 Study: Who Needs Paclitaxel |
Presenter(s):Michael K.W. Lichtenberg, MD / Peter Gaines, MD / Timothy M. Sullivan, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
ARTERIAL PTFE BYPASSES | |
1:06 PM - 1:11 PM Power Point Presentation with Synched Audio |
RCT Comparing Heparin Bonded PTFE (Propaten) Grafts With Plain PTFE Grafts For BTK CLTI Bypasses: Is Heparin Bonding Helpful |
Presenter(s):Yann Gouëffic, MD, PhD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | Hybrid Fluoroscopically Guided Improved Method For Restoring Patency To Occluded PTFE Bypasses: It’s Less Invasive And More Effective |
Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
PERCUTANEOUS BYPASSES | |
1:18 PM - 1:23 PM | Percutaneous (PQ) Tranvenous Fempop PTFE Bypasses With The Torus 2 Device: How It Works And Status Of The DETOUR And TORUS Trials In The US And Europe |
Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Ehrin Armstrong, MD / Peter A. Schneider, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | 3-Year Results Of The Detour PQ Fempop Arterial Bypass Routed Through TheFemoral Vein: Will It Make Open Bypass Obsolete |
Presenter(s):Dainis K. Krievins, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | A Novel Technique For PQ Fempop Bypass Routing The PTFE Bypass Through The Soft Tissue Of The Thigh: How To Do It And Early Results |
Presenter(s):Pierre G. Sarradon, MD / Jean-Pierre Becquemin, MD, FRCS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
NEW INFORMATION ON STENT-GRAFTS | |
1:36 PM - 1:41 PM | 2-Year Results Of The SUPER B RCT Shows That Viabahn Stent-Grafts Have Patency Rates As Good As Open Fempop PTFE Bypasses But Require More Reinterventions: How To Make Viabahns Work Best |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
TREATMENT OF IN STENT RESTENOSIS (ISR) | |
1:42 PM - 1:47 PM | Laser Atherectomy May Facilitate Endovascular Treatment Of ISR But Does Not Provide Long-Term Benefit: How Should ISR Be Treated |
Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | The Excimer Laser For Treating ISR: It Has A Role In Grossing And Debulking Difficult Lesions: Technical Tips |
Presenter(s):Craig M. Walker, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Mark K. Eskandari, MD / Gregg S. Landis, MD |
|
x | |
2:00 PM - 2:05 PM | Update On The BEST-CLI RCT Comparing Endovascular And Open Treatment Of Lower Extremity Ischemia: Current Status, Challenges And What Will Be Its Value |
Presenter(s):Matthew T. Menard, MD / Alik Farber, MD, MBA / Kenneth Rosenfield, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
METHODS FOR EVALUATING FOOT PERFUSION | |
2:06 PM - 2:11 PM Power Point Presentation with Synched Audio |
Measuring Foot Perfusion After Endo Treatments For CLTI With Perfusion Angiography And Smart Software: Why It Is Important And How To Do It |
Presenter(s):Jim Reekers, MD, PhD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
2:12 PM - 2:17 PM | Indocyanine Green Fluorescence (IGC-FL) Is A Good Way To Measure Foot Perfusion After Treatment: How It Explains Why The Angiosome Concept Is Important After Endo Treatments But Not After Bypasses |
Presenter(s):Maarit Venermo, MD, PhD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
2:18 PM - 2:23 PM | How And Why To Measure Foot Perfusion During Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc: When Is The Angiosome Concept Helpful; When Not |
Presenter(s):Marianne Brodmann, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
2:24 PM - 2:29 PM | What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology, Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters |
Presenter(s):Ido Weinberg, MD, MSc Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
2:30 PM - 2:35 PM | Pedal Arch Patency Is Key To Predicting Limb Salvage With Endovascular Treatment For CLTI With Tissue Necrosis: How Is It Best Evaluated |
Presenter(s):Hasan H. Dosluoglu, MD / Linda Harris, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
2:36 PM - 2:41 PM | Foot Perfusion Measurements Show Why Open Bypasses Are Better Than Endovascular Treatments For CLTI |
Presenter(s):Werner Lang, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
2:42 PM - 2:48 PM | Panel Discussion |
2:48 PM - 3:08 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Matthew T. Menard, MD / Caitlin W. Hicks, MD, MS |
|
x | |
INTERMITTENT CLAUDICATION (IC) | |
3:08 PM - 3:13 PM | Overuse Of Vascular Interventions For IC Is A Measure Of Poor Care: How Is This Determined |
Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
ACUTE LIMB ISCHEMIA (ALI) (See Also Session 59) | |
3:14 PM - 3:19 PM | Update On Thrombosuction Devices For Treating ALI: Which Device In Which Circumstance: Advantages And Limitations |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
3:20 PM - 3:25 PM | Computer Aided Mechanical Aspiration Thrombectomy (CMAT) Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best When And Why |
Presenter(s):Patrick E. Muck, MD, FACS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
3:26 PM - 3:31 PM | Aspiration Thrombectomy Devices And Techniques For ALI: Are Thrombolytics And Fogarty Balloon Catheters Obsolete |
Presenter(s):Maria A. Ruffino, MD, EBIR Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
3:32 PM - 3:37 PM | Penumbra Indigo Clot Aspiration System To Treat ALI: Why Is It A Game Changer: Technical Tips For Usage |
Presenter(s):James F. Benenati, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
3:38 PM - 3:43 PM | Value And Technical Tips For Using The Indigo Clot Removal System Before Treating ISR And Other Lesions With Balloon And Stents |
Presenter(s):Frank R. Arko, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
3:44 PM - 3:49 PM | How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
3:50 PM - 3:56 AM | Panel Discussion |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, NEW ANTIATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Ido Weinberg, MD, MSc / Bhama Ramkhelawon, PhD |
|
x | |
3:56 PM - 4:01 PM | What Adequate And Ideal Lipid Levels Should We Strive For In PAD Patients: How To Get There |
Presenter(s):Marianne Brodmann, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:02 PM - 4:07 PM | Risks And Consequences Of Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients: What Can Be Done To Decrease MI Incidence And Their Morbidity And Mortality When They Occur |
Presenter(s):Peter Henke, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:08 PM - 4:13 PM Power Point Presentation with Synched Audio |
Update On LDL-C Lowering During A Lifetime: How Low To Strive For; How Young To Start If High; How Old To Continue Statins |
Presenter(s):J. David Spence, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:14 PM - 4:19 PM | DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:20 PM - 4:25 PM | DEBATE: Not So: LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death |
Presenter(s):Ron Waksman, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:26 PM - 4:31 PM | Low Dose Rivaroxaban And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo And Open Treatments For PAD/CLTI: From The VOYAGER RCT |
Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:32 PM - 4:37 PM | How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:38 PM - 4:43 PM | New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For |
Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:44 PM - 4:50 PM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Christopher K. Zarins, MD / Michael R. Jaff, DO |
|
x | |
UPDATE ON RENAL DENERVATION FOR HYPERTENSION | |
4:50 PM - 4:55 PM | Current Status Of Renal Denervation For Drug Resistant Hypertension: Why The Simplicity Spyral Radiofrequency Denervation System Is Different: Status Of The SPYRAL HTN-OFF MED RCT (Versus Sham) |
Presenter(s):Sahil A. Parikh, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
4:56 PM - 5:01 PM | Preop Cardiac Evaluation With CT-Based Fractional Flow Reserve (FFRCT) And Selective Coronary Revascularization Saves Lives In Patients Undergoing Procedures For CLTI And Carotid Disease |
Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
5:02 PM - 5:07 PM Power Point Presentation with Synched Audio |
How And Why Do Thoracic Stent-Grafts For TEVAR Negatively Affect The Heart |
Presenter(s):Frans L. Moll, MD, PhD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
5:08 PM - 5:13 PM | Permissive Transfusion Strategies Increase Mortality And Serious Adverse Events After Major Vascular And General Surgery Operative Interventions |
Presenter(s):Panos Kougias, MD, MSc Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
5:14 PM - 5:19 PM | Vascular Complications Of COVID-19 Infections: What Is Known And Unknown: How To Diagnose And Treat |
Presenter(s):Michael E. Barfield, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
5:20 PM - 5:25 PM Power Point Presentation with Synched Audio |
Cardiac Complications Of COVID-19 Infections: What Is Their Genesis: Diagnosis And Treatment |
Presenter(s):Roxana Mehran, MD Location: LECTURE HALL 1 - BONNET CREEK BALLROOM |
|
View Slides in PDF | |
5:26 PM - 5:31 PM | Panel Discussion |
5:31 PM - 5:31 PM | End of Program C |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
|
|
x | |
TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS | |
7:00 AM - 7:05 AM | Most Type 2 Endoleaks Are Benign: The Case Can Be Made That By Treating Type 2 Endoleaks The Harm And Cost Of Such Treatment Outweighs The Benefits: When If Ever Should They Be Treated; AAA Sac Behavior Predicts Late Survival After EVAR |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
TREATING TYPE 1 ENDOLEAKS | |
7:06 AM - 7:11 AM | Type 1A Endoleaks After EVAR Are Predictable And Preventable: How To Do So |
Presenter(s):Michael J. Singh, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
7:12 AM - 7:17 AM | When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately |
Presenter(s):Sigrid Nikol, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
7:18 AM - 7:23 AM Power Point Presentation with Synched Audio |
How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How To Treat Them When They Occur: When Not To Treat Them |
Presenter(s):Konstantinos P. Donas, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
7:24 AM - 7:29 AM Power Point Presentation with Synched Audio |
Shape Memory Technology For AAA Sac Filling: How Does It Work And Why It May Be A Better Form Of EVAR |
Presenter(s):Andrew Holden, MBChB Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
ROLE OF INFLAMMATION | |
7:30 AM - 7:35 AM | The Role Of Inflammation In Causing Late Endoleaks: How To Evaluate It And How Should It Influence Treatment |
Presenter(s):Furuzan Numan, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
7:36 AM - 7:42 AM | Panel Discussion |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR
|
|
x | |
7:42 AM - 7:47 AM Power Point Presentation with Synched Audio |
A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: Confirmed By A Japanese RCT: When And How To Do It |
Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
7:48 AM - 7:53 AM | With A Large IMA (> 3mm), When Should It Be Embolized; When Should It Be Revascularized And Why |
Presenter(s):Piotr M. Kasprzak, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
TREATMENT OF TYPE 2 ENDOLEAKS AFTER EVAR | |
7:54 AM - 7:59 AM | How Duplex Ultrasound Velocities In Type 2 Endoleaks Determine Behavior And Help In Treatment: Technical Tips |
Presenter(s):Ross Milner, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:00 AM - 8:05 AM | Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It |
Presenter(s):Neal S. Cayne, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:06 AM - 8:11 AM | Transcaval Access To AAA Sacs For Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It |
Presenter(s):Adam Beck, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:12 AM - 8:17 AM | How To Best Leverage 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Value Of Transcaval Access |
Presenter(s):Mark W. Mewissen, MD, RVT Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:18 AM - 8:23 AM | Transgraft Approach To Treat Type 2 Endoleaks: Indications, Equipment, Advantages And Precautions |
Presenter(s):James F. McKinsey, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:24 AM - 8:29 AM | Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique |
Presenter(s):Zvonimir Krajcer, MD, FACC Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:30 AM - 8:35 AM | With Type 2 Endoleaks And Sac Expansion Open Sacotomy And Branch Ligation Is The Best Treatment: Why And What Precautions Are Needed To Be Sure There Is Not Occult Type 1 Leak |
Presenter(s):Zachary M. Arthurs, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:36 AM - 8:48 AM | Panel Discussion |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs) AND THEIR TREATMENT
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Ramon Berguer, MD, PhD / Paulo E. Ocke Reis, MD, PhD |
|
x | |
8:48 AM - 8:53 AM | False Lumen Area >50% Of Total Aortic Cross-Section Area At The Tracheal Bifurcation At Time Of TEVAR For TBAD Is A Predictor Of Early Death: How To Decrease This Mortality |
Presenter(s):Johnny Steuer, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
8:54 AM - 8:59 AM | Results From A Global Multicenter Registry On Candy Plug In Chronic TBAD |
Presenter(s):Tilo Koelbel, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
9:00 AM - 9:05 AM | Staged Hybrid Single Lumen Reconstruction Is The Best Treatment For Complex Chronic TBAD With Visceral Segment Involvement Of The Aorta: How To Do It, Advantages And Results |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
9:06 AM - 9:11 AM | Reinterventions After TEVAR For TBADs: How To Decrease Them At The Index Procedure And How Planning Helps |
Presenter(s):Bijan Modarai, PhD, FRCS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
9:12 AM - 9:17 AM | Adjunctive Peripheral And Visceral Interventions During TEVAR For Complicated TBADs: Indications, Technical Tips And Results |
Presenter(s):Mark K. Eskandari, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
9:18 AM - 9:23 AM | Update On Intramural Hematoma (IMH): Etiology, Natural History And Indications For TEVAR |
Presenter(s):Frank J. Criado, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
9:24 AM - 9:30 AM | Panel Discussion |
9:30 AM - 9:42 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
MORE ADVANCES RELATED TO LESIONS INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Rodney A. White, MD / Alan B. Lumsden, MD, FACS |
|
x | |
9:42 AM - 9:47 AM | Value Of Transcranial Doppler (TCD) For TEVAR And Endo Procedures Involving The Ascending Aorta And Aortic Arch |
Presenter(s):Alan B. Lumsden, MD, FACS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
9:48 AM - 9:53 AM | Antegrade Stent-Graft Delivery For Treating Acute Type A Dissections: When Is It Advantageous And How To Do It |
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
9:54 AM - 9:59 AM | The Pulley Effect: Endovascular Instrumentation At The Aortic Bifurcation Generates Unexpected Forces That May Tear The Aorta |
Presenter(s):Martin Malina, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:00 AM - 10:05 AM | For Precise TEVAR In The Aortic Arch Rapid Pacing And Caval Occlusion Are NOT Needed: Valsalva And PEEP By Anesthesiologist Do Just As Well And Are Simple: Technical Tips |
Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:06 AM - 10:11 AM | Arch Lesion Repair With Single, Double Or 3-Branched Devices: When Is Each Best And Why |
Presenter(s):Gustavo S. Oderich, MD, FACS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:12 AM - 10:17 AM | Laser Fenestration Option For TEVAR Involving The Great Arch Branches: When Is It Better Than Branched Endografts: Technique And Results |
Presenter(s):Timothy A. Resch, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:18 AM - 10:26 AM | Panel Discussion |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Giovanni B. Torsello, MD / Gustavo S. Oderich, MD, FACS |
|
x | |
COMPLEX AAAs AND TAAAs | |
10:27 AM - 10:32 AM | Open Repair Is The Best Way To Treat Short Neck, No Neck And Pararenal AAAs: Why Is This So |
Presenter(s):Laurent Chiche, MD, FEBVS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:33 AM - 10:38 AM | Comparative Morbidity And Mortality Outcomes Of Open, Hybrid And F/B/EVAR For Type II And III TAAAs Justify Greater Use Of F/B/EVAR For These Complex Lesions |
Presenter(s):Gilbert R. Upchurch, MD / Salvatore T. Scali, MD / Dean Arnaoutakis, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:39 AM - 10:44 AM | New Techniques To Improve The Open Repair Of TAAAs |
Presenter(s):Laurent Chiche, MD, FEBVS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
TOPICS RELATED TO INTERESTING NEW DEVICES | |
10:45 AM - 10:50 AM | A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Early Clinical Experience And Advantages |
Presenter(s):Sebastian E. Debus, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:51 AM - 10:56 AM | How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur |
Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
10:57 AM - 11:02 AM | Role Of Device Engineering On Sac Regression Seen With The TREO Endograft |
Presenter(s):Michael C. Stoner, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:03 AM - 11:08 AM | Update On The Colt Manifold Device For TAAAs, Complex AAAs, Failed EVARs And Failed EVAS Procedures: How Does It Work And Results |
Presenter(s):Piotr Szopinski, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:09 AM - 11:17 AM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Thomas S. Maldonado, MD / Rodney A. White, MD |
|
x | |
TREATMENT OF ILIAC ANEURYSMS AND IBDs | |
11:18 AM - 11:23 AM Power Point Presentation with Synched Audio |
DEBATE: How Best To Treat Iliac Aneurysms In 2021: There Is Not Much Of A Need For Open Surgery |
Presenter(s):Stefan Mueller-Huelsbeck, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:24 AM - 11:29 AM | DEBATE: There Is A Role For Open Surgery In The Treatment Of Iliac Aneurysms: What Is It And Technical Tips |
Presenter(s):Heron E. Rodriguez, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:30 AM - 11:35 AM | Long-Term Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Advantages And Limitations |
Presenter(s):Giovanni B. Torsello, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:36 AM - 11:41 AM | Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Advantages And Limitations: From The European ICEBERG Registry |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:42 AM - 11:47 AM | Advantages And Limitations Of The Jotec-Cryolite Iliac Branch Device For Treating Common And Internal Iliac Artery Aneurysms |
Presenter(s):Lee Bouwman, MD, PhD, MSc Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:48 AM - 11:53 AM | MLFM Bare Stent (From Cardiatis) Is A Promising Treatment For Acute Aortic Dissections: What Is The Evidence In Support |
Presenter(s):Rodney A. White, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Thomas S. Maldonado, MD / Fiona Rohlffs, MD |
|
x | |
1:00 PM - 1:05 PM | A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And Early Clinical Results |
Presenter(s):Venkatesh G. Ramaiah, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
AAA NECK BEHAVIOR AFTER EVAR | |
1:06 PM - 1:11 PM | Impact Of Oversizing And Level Of Fixation (Infra Versus Supra-Renal) On Aortic Neck Behavior: How Do These Variables Affect EVAR Outcomes: From A 10-Year Study |
Presenter(s):Carlos F. Bechara, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | Aortic Neck Dilatation Is Different After F/EVAR And EVAR: What Is The Reason And Why Is It Important For Outcomes |
Presenter(s):Thomas S. Maldonado, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts |
Presenter(s):Jan D. Blankensteijn, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | Do AAA Necks Dilate After F/EVAR For Juxtarenal AAAs: What Are The Good Or Bad Consequences For Procedural Outcomes |
Presenter(s):Benjamin W. Starnes, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Not So: Ovation Stent-Graft (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft |
Presenter(s):Mahmoud B. Malas, MD, MHS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:42 PM - 1:47 PM | Current Status Of The Link Between EVAR And Cancer: Is It Real And What Is Its Etiology |
Presenter(s):Janet T. Powell, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | Presenting AAAs As Ticking Time Bombs Or Unexploded Grenades Is Wrong-Headed, Inaccurate And Harmful |
Presenter(s):Frank J. Criado, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
MORE NEW DEVELOPMENTS IN AAAs: HOW DO THEIR NECK AND SAC SIZE AND THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Ali F. AbuRahma, MD / Janet T. Powell, MD, PhD |
|
x | |
AAA NECK AND SAC THROMBUS LOAD | |
2:00 PM - 2:05 PM | DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity With And Without Rupture: What Is The Mechanism And How To Quantitate Thrombus Load |
Presenter(s):David H. Deaton, MD, FACS Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
2:06 PM - 2:11 PM | DEBATE: Large Flow Lumenal Space In AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
2:12 PM - 2:17 PM | Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It |
Presenter(s):Ashraf Mansour, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
2:18 PM - 2:23 PM | Large AAA Necks (> 29 mm) Increase Migration And Leak Risks After EVAR With Self-Expanding Endografts Due To Neck Dilatation: Not So With Anatomically Adaptive (Polymer) Sealing Endografts (Ovation) Which Are Not Followed With Neck Dilatation |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
2:24 PM - 2:29 PM | Does Doxycycline Stabilize AAA Neck Diameter: From The NTACT Trial |
Presenter(s):Jon S. Matsumura, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
2:30 PM - 2:35 PM | EVAS With Sac Filling Technology (Nellix) Has Lower Late Mortality Than EVAR With Other Endografts – Especially With Large AAAs: What Is The Mechanism Thought To Be |
Presenter(s):Marc L. Schermerhorn, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
2:36 PM - 2:42 PM | Panel Discussion |
2:42 PM - 2:56 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
HOT AORTIC TOPICS (4 ¾ AND 5--MINUTE FAST PACED TALKS)
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Timothy A.M. Chuter, DM / Luis A. Sanchez, MD |
|
x | |
2:56 PM - 3:01 PM | A Large Proportion Of EVARs Are Performed On Small AAAs: What Are The Implications And What Should Be Done About It |
Presenter(s):Salvatore T. Scali, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:01 PM - 3:06 PM | Late Delayed Renal Artery Revascularization After Inadvertent Occlusion During Complex EVAR Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced |
Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:06 PM - 3:11 PM | How Can A Long-Term Aortic Risk (LEAR) Model Predict Mortality And Complication Risks And Guide Surveillance: Can The Model Be Made Device Specific |
Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:12 PM - 3:17 PM | Visceral Debranching With A Simple Aortic Endograft Is The Best Way To Treat AAAs In Good Risk Patients: How To Do It Safely |
Presenter(s):Guillermo A. Escobar, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:18 PM - 3:23 PM | Update On Maintaining Euglycemia To Decrease Spinal Cord Ischemia With Complex AAA And TAAA Repairs |
Presenter(s):Jade S. Hiramoto, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:24 PM - 3:29 PM | Incidence And Etiology Of Cerebrovascular Injuries With Acute TBADs With And Without Treatment |
Presenter(s):Loay S. Kabbani, MD, MHSA Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:30 PM - 3:35 PM | EVAR, F/EVAR And B/EVAR Results In Females: Are There Still Differences |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:36 PM - 3:41 PM | Update On Performing EVAR With Only IVUS Guidance To Decrease Radiation: Technical Tips And 3-Year Results |
Presenter(s):Jörg Tessarek, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:42 PM - 3:47 PM | Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation >6 Years After EVAR With Self-Expanding Endografts: Does The Neck Keep Dilating After The Spring Is Gone: What Are The Differences Between Excluder And Endurant Endografts |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
3:48 PM - 3:58 PM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
MORE SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASE AND ITS TREATMENT AND MISCELLANEOUS TOPICS
|
|
x | |
3:58 PM - 4:03 PM | Impact Of Iliac Aneurysms On The Treatment Of Complex AAAs |
Presenter(s):Matthew J. Eagleton, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:04 PM - 4:09 PM | How To Treat AAAs With Large (>34 mm Diameter) Necks: When EVAR; When F/EVAR; When Open |
Presenter(s):Rabih A. Chaer, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:10 PM - 4:15 PM | A New Gene Family In AAA Smooth Muscle Is Related To Aneurysm Diameter And Rupture: Could It Be A Screening Tool |
Presenter(s):Kak Khee Yeung, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:16 PM - 4:21 PM | How Should Intramural Hematomas (IMHs) In The Ascending Aorta And Arch Be Treated |
Presenter(s):Jennifer L. Perri, MD, MBA / Timothy A.M. Chuter, DM Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:22 PM - 4:27 PM | How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results |
Presenter(s):Luis A. Sanchez, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:28 PM - 4:33 PM | The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It |
Presenter(s):Sukgu Han, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:34 PM - 4:39 PM | Comparison Of Endo And Open (Carotid-Subclavian Bypass) Treatments For Subclavian Artery Stenosis And Occlusions: Safety, Durability And Costs |
Presenter(s):Ali F. AbuRahma, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:40 PM - 4:46 PM | Panel Discussion |
MISCELLANEOUS TOPICS | |
4:46 PM - 4:51 PM | Propensity Score Matching Studies: How Do They Work And What Are Their Strengths And Weaknesses |
Presenter(s):Charles C. Miller, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:52 PM - 4:57 PM | The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going |
Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
4:58 PM - 5:03 PM | How Can Vascular Surgeons Identify High Risk, High Cost Patients And Help Health Care Systems Control Costs: How To Prevent Inappropriate Treatments In These Patients |
Presenter(s):Lee Kirksey, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:04 PM - 5:09 PM | What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2021: Will Planned Increased Reimbursement For Office And Hospital Visits Cause Decreases In Procedural Reimbursements |
Presenter(s):Sean P. Roddy, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:10 PM - 5:15 PM | What Vascular Injury Killed Martin Luther King, Jr. And Why He Might Have Survived Today |
Presenter(s):Cynthia K. Shortell, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:16 PM - 5:21 PM | Historical Perspective Over The Last 25 Years On FDA Approvals Of EVAR Devices Submitted By Investigators And Industry: Lessons Learned To Guide Future Applications |
Presenter(s):Kenneth Ouriel, MD, MBA / Dorothy B. Abel, BSBME Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:22 PM - 5:27 PM | Are The Quality, Safety And Effectiveness Of Generic Drugs Equating Those Of The Patented Original Drugs: How Is The FDA Assuring Equivalence; Should The FDA Do More |
Presenter(s):Valerie M. Merkle, PhD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:28 PM - 5:34 PM | Panel Discussion |
5:34 PM - 5:39 PM | A Balanced View Of Atherectomy In Outpatient Facilities And OBLs In 2020: Is The Procedure Overused And Why |
Presenter(s):Krishna Jain, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:40 PM - 5:45 PM | Inherent Conflicts Of Interest In OBLs: Why They Occur And Are Bad For Patients: How To Counteract Them |
Presenter(s):O. William Brown, MD, JD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:46 PM - 5:51 PM | Why And How Do Outpatient Angio Suites And OBLs Fail |
Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:52 PM - 5:57 PM | SVS VQI – From Quality Improvement To Disruptive Technology |
Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
5:58 PM - 6:03 PM Power Point Presentation with Synched Audio |
Improved Outcomes Of Type A Aortic Dissections With Use Of Bare Stents (Cardiatis And Ascyrus): They Decrease Malperfusion, Promote Aortic Remodeling And Prevent Strokes: How Do They Work |
Presenter(s):Ralf R. Kolvenbach, MD Location: LECTURE HALL 2 - FLORIDIAN BALLROOM |
|
View Slides in PDF | |
6:04 PM - 6:10 PM | Panel Discussion |
6:10 PM - 6:10 PM | End of Program D |
END OF SESSION 42 |